Mettl3-mediated m6 A modification of Lrp2 facilitates neurogenesis through Ythdc2 and elicits antidepressant-like

Biao Xu1, Qingfeng Li1, Yuanfei Wu1

  • 1Institute of Neuroscience and the Second Affiliated Hospital of Guangzhou Medical University, School of Basic Medical Sciences, Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China.

Insights

N6-methyladenosine (m6A) RNA modification regulates neural stem cell functions. Targeting the Mettl3-Ythdc2-Lrp2 pathway in the hippocampus shows promise for treating depression by enhancing neurogenesis.

Area of Science:

  • Neuroscience
  • Epigenetics
  • Molecular Biology

Background:

  • N6-methyladenosine (m6A) is a prevalent mRNA modification influencing various biological processes.
  • The role of m6A in adult hippocampal neurogenesis and depression is not well understood.

Purpose of the Study:

  • To elucidate the function and mechanism of m6A signaling in hippocampal neurogenesis and depression.
  • To investigate the Mettl3-Ythdc2-Lrp2 axis in regulating neurogenesis.

Main Methods:

  • Depletion and overexpression of Mettl3/Mettl14 in neural stem cells (NSCs).
  • Assessment of m6A levels, cell proliferation, differentiation, and neurogenesis.
  • Analysis of Lrp2 mRNA stability and translation efficiency.
  • Behavioral tests in mice lacking Mettl3 and in a mouse model of depression.

Main Results:

  • Mettl3/Mettl14 depletion reduced m6A, NSC proliferation, and neuronal genesis, while promoting glial differentiation.
  • m6A modification of Lrp2 mRNA by Mettl3 enhanced its stability and translation via Ythdc2, promoting neurogenesis.
  • Mice lacking Mettl3 exhibited impaired hippocampal neurogenesis, spatial memory deficits, and depression-like behaviors, which were reversed by Lrp2 overexpression or Mettl3 reintroduction.

Conclusions:

  • m6A modification, particularly through the Mettl3-Ythdc2-Lrp2 pathway, plays a critical role in hippocampal neurogenesis.
  • This pathway is implicated in depression-related behaviors.
  • Targeting the Mettl3-Ythdc2-Lrp2 axis represents a potential therapeutic strategy for depression.